| Liposome-encapsulated diacyl glycerol and inositol triphosphate-induced delayed oocyte activation and poor development of parthenotes | Satish Kumar ADİGA, Ramya NAİR, Jyothsna MANİKKATH, Aswathi R. HEGDE, Guruprasad KALTHUR | 102–109 |
| Revaluating the survival effects of International Federation of Gynecology and Obstetrics 1988 stage IIIA criteria for endometrial cancer | Taner TURAN, Derman BAŞARAN, Işın ÜREYEN, Alper KARALOK, Osman TÜRKMEN, Günsu KİMYON, Gizem KUL, Gökhan TULUNAY | 110–115 |
| Risk factors for appendiceal involvement in women with epithelial ovarian cancer | Elmas KORKMAZ, Mustafa Erkan SARI, Tayfun GÜNGÖR, Murat ÖZ, Mehmet Mutlu MEYDANLI | 116–121 |
| Platelet-to-lymphocyte ratio: A new inflammatory marker for the diagnosis of preterm premature rupture of membranes | Eray ÇALIŞKAN, Musa SİLAHLI, Erzat TOPRAK, Ayşe ENDER YUMRU, Burcu Dinçgez ÇAKMAK, Murat BOZKURT, Emel Ebru ÖZÇİMEN | 122–126 |
| Lymph node dissection in atypical endometrial hyperplasia | Fırat ORTAÇ, Özgür KAN, Salih TAŞKIN, Kazibe KOYUNCU, Mete GÜNGÖR, Ayşegül ALKILIÇ, Ömer DAİ, Elif A. Taşkın | 127–132 |
| Blastocyst transfer does not improve cycle outcome as compared to D3 transfer in antagonist cycles with an elevated progesterone level on the day of hCG | Faruk BUYRU, Cem DEMİREL, Serkan AYDOĞDU, Arzu İlknur ÖZDEMİR, Gülşah KESKİN, Ercan BAŞTU | 133–138 |
| Microcystic, elongated, and fragmented pattern of invasion in relation to histopathologic and clinical prognostic factors in endometrioid endometrial adenocarcinoma | İlknur TÜRKMEN, Gülbin ORAN, Faruk KÖSE, M. Murat NAKİ, Seza Ümit TETİKKURT, Cavide Fatma SÖNMEZ | 139–142 |
| Exploring the umbilical and vaginal port during minimally invasive surgery | Farr NEZHAT, Tahar BENHIDJEB, Andrea TİNELLİ, Antonello FORGİONE, Ricardo ZORRON, Giovanni DAPRİ, Antonio MALVASİ, Radmila SPARİC, Daniel A. TSİN | 143–147 |
| How to personalize ovarian stimulation in clinical practice | Antonio LA MARCA, Giovanna SİGHİNOLFİ, Valentina GRİSENDİ | 148–153 |